RxDoctor Payments Data

Richard Glines, MD

Interventional Pain Medicine · Salt Lake City, UTNPI 1790794063

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,986 of the $3,615 with a category attached, or 82.6%. 16 manufacturers reported payments, led by Boston Scientific at 35.0% of the total. Reporting peaked in 2022 at $1,304 and has fallen 53.3% since, to $609 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.

$3,615in general payments, 2019–2025

Across 169 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Relievant Medsystems, Inc.$827
  • Medtronic$548
  • AbbVie$435
  • Stryker$147
  • Biotronik NRO, Inc.$113
  • plus $281 from 10 others

What the payments were for

  • Travel & lodging$62917%
  • Food & beverage$2,98683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific63$1,265
Relievant Medsystems, Inc.7$827
Medtronic(2 entities)44$548
AbbVie(2 entities)30$435
Stryker7$147
Biotronik NRO, Inc.3$113
Nalu Medical, Inc.2$55
Amgen3$54
Nevro Corp.2$48
Avanos Medical1$25
Pfizer2$24
Biohaven Pharmaceuticals, Inc.1$21
Si-bone, Inc.1$17
Bioventus LLC1$14
Abbott1$13
Stratus Medical, LLC1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,615 in reported general payments places this provider in the 20th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$155,375
Medicare patients
322
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nucynta ErTapentadol Hcl11$13,947
Buprenorphine29$6,572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen114$584
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$500
Tramadol Hcl138$466
Acetaminophen-CodeineAcetaminophen With Codeine74$428
Morphine Sulfate ErMorphine Sulfate16$385
Gabapentin59$356
Oxycodone Hcl36$340
Celecoxib11$329
Pregabalin18$264
Tizanidine Hcl37$229
Duloxetine Hcl12$53
Prednisone18$47

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →